Andrea Sneider Hakimi is a Greenville, South Carolina based neurologist with 23 years of experience in Clinical Neurophysiology. She completed her graduation from Michigan State University College Of Osteopathic Medicine in 2001. She is also affiliated with hospitals like and . She accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Andrea Sneider Hakimi is 39369 for Neurology in South Carolina. Her current practice location is 200 Patewood Dr, Suite B350, Greenville. Patients can reach her at 864-454-4500 or can fax her at 864-454-4505. Andrea Sneider Hakimi is D.O. in Clinical Neurophysiology and her NPI number (Unique professional ID assigned by NPPES) is 1679681308. Andrea Sneider Hakimi is subspecialized with psychiatric or neurologic expertise in the diagnosis and management of central, peripheral, and autonomic nervous system disorders using combined clinical evaluation and electrophysiologic testing such as electroencephalography (EEG), electromyography (EMG), and nerve conduction studies (NCS).
Complete Profile:
Andrea Sneider Hakimi speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Andrea Sneider Hakimi
Specialization:
Clinical Neurophysiology
Gender:
Female
Credentials:
D.O.
Experience:
23+ years
Medical School Attended:
Michigan State University College Of Osteopathic Medicine
Graduation Year:
2001
Accepts Medicare Assignment:
Yes
Practice Address:
200 Patewood Dr, Suite B350, Greenville, South Carolina, 29615-3593
Phone:
864-454-4500
Fax:
864-454-4505
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
3173520608
Enrollment ID:
I20160920000650
NPI Number:
1679681308
NPI Enumeration Date:
25 Aug, 2006
NPI Last Update On:
23 Sep, 2016
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Andrea Sneider Hakimi are as mentioned below.
License Number
Specialization
State
Status
39369
Neurology
South Carolina
Primary
4769
Clinical Neurophysiology
Oklahoma
Secondary
4769
Neurology
Oklahoma
Secondary
Hospital Affiliation:
Surgeons are affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
Hospital Name (CCN)
State
Hospital Type
(420078)
Greenville, SC
Acute Care Hospital
(420102)
Greenville, SC
Acute Care Hospital
(420015)
Easley, SC
Acute Care Hospital
(420009)
Seneca, SC
Acute Care Hospital
(420038)
Clinton, SC
Acute Care Hospital
Group Practice:
Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name
with which Andrea Sneider Hakimi is associated with along with the number of members in that group.
Organization Name (Group PAC ID)
Members
Prisma Health University Medical Group (8325950983)
2095
Other Medical Identifiers:
Other legacy medical identifiers associated with Andrea Sneider Hakimi such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
393693
Medicaid
South Carolina
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Andrea Sneider Hakimi 1 Independence Pt, Suite 212 Greenville, South Carolina
Zip:
29615-4545
Phone Number:
864-797-6306
Patients can reach Andrea Sneider Hakimi at 200 Patewood Dr, Suite B350, Greenville, South Carolina or can call to book an appointment on 864-454-4500.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.